PALISADE BIO, INC.PALIEarnings & Financial Report
Nasdaq · Health Care · Biological Products, (No Diagnostic Substances)
Palisade Bio, Inc. is a clinical-stage biopharmaceutical firm developing novel therapies for gastrointestinal and associated inflammatory disorders. Its lead product candidates address unmet medical needs including post-surgical intestinal complications and chronic digestive conditions, operating primarily in the U.S. healthcare market.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| Armistice Capital, LLC | 9.99% | 125.7K | ▲ +5.00pp | 2024-11-14 |
| Mitchell | 1.90% | 180.5K | — | 2024-02-06 |
| Nos. of above persons | 1.70% | 158.4K | ▼ -6.20pp | 2024-02-13 |
| L1 Capital Global Opportunities Master Fund, Ltd. | 0.00% | 696.4M | ▼ -6.40pp | 2024-02-09 |
Insider Transactions
Net 90d: +$0 · buys $0 / sells $0Range:
Action:
Role:
No transactions match these filters.